(Q73446054)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Stein RS

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Greer JP

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Goodman S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Brandt SJ

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Morgan DS

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Macon WR

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

McCurley TL

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Wolff SN

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

257-262

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673696%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702132

4 November 2019

exact match

0 references

cites work

Treatment of Resistant Malignant Lymphoma with Cyclophosphamide, Total Body Irradiation, and Transplantation of Cryopreserved Autologous Marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702132

7 January 2021